Coronary Angioplasty
10
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
60%
6 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
DIstal vs Proximal Radial Artery Access for Cath
Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg
Effect of Music on the Sedative Use During Coronary Angioplasty
Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation
Customized Choice of Oral P2Y12 Receptor Blocker
Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC Trial
Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
Feeding Education in Patients Submitted to Coronary Angioplasty